{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:07:22Z","timestamp":1789200442579,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12010-026-05640-x","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:36:35Z","timestamp":1781073395000},"page":"7025-7047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decreasing S1PR3 Alleviated Renal Tubular Lipid Deposition in Diabetic Nephropathy via AMPK\/PPAR-\u03b3\/GPAT3 Pathway"],"prefix":"10.1007","volume":"198","author":[{"given":"Xiaohui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"5640_CR1","doi-asserted-by":"crossref","unstructured":"Sagoo, M. K. & Gnudi, L. (2020). Diabetic Nephropathy: An Overview. Methods in molecular biology (Clifton NJ), 2067, 3\u20137.","DOI":"10.1007\/978-1-4939-9841-8_1"},{"key":"5640_CR2","first-page":"411","volume":"71","author":"BP Lucke-Wold","year":"2014","unstructured":"Lucke-WoldBP, LogsdonAF, TurnerRC, RosenCL, & Huber, J. D. (2014). Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease. Advances in pharmacology (San Diego Calif), 71, 411\u2013449.","journal-title":"Advances in pharmacology (San Diego Calif)"},{"key":"5640_CR3","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu, N. (2021). Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed research international, 2021, 1497449.","journal-title":"BioMed research international"},{"issue":"1","key":"5640_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s40001-023-01479-8","volume":"28","author":"A Rezaei Shahrabi","year":"2023","unstructured":"Rezaei Shahrabi, A., Arsenault, G., Nabipoorashrafi, S. A., Lucke-Wold, B., Yaghoobpoor, S., Meidani, F. Z., et al. (2023). Relationship between neutrophil to lymphocyte ratio and diabetic peripheral neuropathy: a systematic review and meta-analysis. European journal of medical research, 28(1), 523.","journal-title":"European journal of medical research"},{"issue":"2","key":"5640_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.arr.2006.03.004","volume":"5","author":"M Slawik","year":"2006","unstructured":"Slawik, M., & Vidal-Puig, A. J. (2006). Lipotoxicity, overnutrition and energy metabolism in aging. Ageing research reviews, 5(2), 144\u2013164.","journal-title":"Ageing research reviews"},{"issue":"1","key":"5640_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M., Ahn, S. H., Choi, P., Ko, Y. A., Han, S. H., Chinga, F., et al. (2015). Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nature medicine, 21(1), 37\u201346.","journal-title":"Nature medicine"},{"issue":"3","key":"5640_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann, J. A., & Carvalho, P. (2019). Dynamics and functions of lipid droplets. Nature reviews Molecular cell biology, 20(3), 137\u2013155.","journal-title":"Nature reviews Molecular cell biology"},{"key":"5640_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","volume":"108","author":"F Seebacher","year":"2020","unstructured":"Seebacher, F., Zeigerer, A., Kory, N., & Krahmer, N. (2020). Hepatic lipid droplet homeostasis and fatty liver disease. Seminars in cell & developmental biology, 108, 72\u201381.","journal-title":"Seminars in cell & developmental biology"},{"key":"5640_CR9","doi-asserted-by":"publisher","first-page":"104778","DOI":"10.1016\/j.phrs.2020.104778","volume":"156","author":"K Su","year":"2020","unstructured":"Su, K., Yi, B., Yao, B. Q., Xia, T., Yang, Y. F., Zhang, Z. H., et al. (2020). Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis. Pharmacological research, 156, 104778.","journal-title":"Pharmacological research"},{"issue":"11","key":"5640_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41419-021-04326-y","volume":"12","author":"Y Han","year":"2021","unstructured":"Han, Y., Xiong, S., Zhao, H., Yang, S., Yang, M., Zhu, X., et al. (2021). Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy. Cell death & disease, 12(11), 1031.","journal-title":"Cell death & disease"},{"issue":"1","key":"5640_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-022-00545-x","volume":"28","author":"C Zhao","year":"2022","unstructured":"Zhao, C., Li, L., Li, C., Tang, C., Cai, J., Liu, Y., et al. (2022). PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease. Molecular medicine (Cambridge Mass), 28(1), 117.","journal-title":"Molecular medicine (Cambridge Mass)"},{"issue":"10","key":"5640_CR12","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.2337\/db21-0050","volume":"70","author":"L Wu","year":"2021","unstructured":"Wu, L., Liu, C., Chang, D. Y., Zhan, R., Zhao, M., Man Lam, S., et al. (2021). The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK\/PPAR\u03b1\/CPT1b Pathway. Diabetes, 70(10), 2192\u20132203.","journal-title":"Diabetes"},{"issue":"1","key":"5640_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","volume":"18","author":"J Baek","year":"2022","unstructured":"Baek, J., He, C., Afshinnia, F., Michailidis, G., & Pennathur, S. (2022). Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nature reviews Nephrology, 18(1), 38\u201355.","journal-title":"Nature reviews Nephrology"},{"key":"5640_CR14","doi-asserted-by":"publisher","unstructured":"Opazo-R\u00edos, L., Mas, S., Mar\u00edn-Royo, G., Mezzano, S., G\u00f3mez-Guerrero, C., & Moreno, J. A. (2020). Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities. International Journal of Molecular Sciences, 21(7). https:\/\/doi.org\/10.3390\/ijms21072632","DOI":"10.3390\/ijms21072632"},{"key":"5640_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jnutbio.2018.02.017","volume":"57","author":"R Varshney","year":"2018","unstructured":"Varshney, R., Varshney, R., Mishra, R., Gupta, S., Sircar, D., & Roy, P. (2018). Kaempferol alleviates palmitic acid-induced lipid stores, endoplasmic reticulum stress and pancreatic \u03b2-cell dysfunction through AMPK\/mTOR-mediated lipophagy. The Journal of nutritional biochemistry, 57, 212\u2013227.","journal-title":"The Journal of nutritional biochemistry"},{"issue":"11","key":"5640_CR16","doi-asserted-by":"publisher","first-page":"e23227","DOI":"10.1096\/fj.202301162R","volume":"37","author":"X Ji","year":"2023","unstructured":"Ji, X., Chen, J., You, C., Sun, J., & Xu, X. (2023). Leflunomide alleviates obesity via activation of the TAK1-AMPK pathway and induction of lipophagy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 37(11), e23227.","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"7","key":"5640_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1248\/bpb.b17-00724","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang, Q., Liu, S., Zhai, A., Zhang, B., & Tian, G. (2018). AMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation. Biological & pharmaceutical bulletin, 41(7), 985\u2013993.","journal-title":"Biological & pharmaceutical bulletin"},{"issue":"10","key":"5640_CR18","doi-asserted-by":"publisher","first-page":"E1176","DOI":"10.1152\/ajpendo.00666.2013","volume":"306","author":"J Cao","year":"2014","unstructured":"Cao, J., Perez, S., Goodwin, B., Lin, Q., Peng, H., Qadri, A., et al. (2014). Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity. American journal of physiology Endocrinology and metabolism, 306(10), E1176\u2013E1187.","journal-title":"American journal of physiology Endocrinology and metabolism"},{"issue":"6","key":"5640_CR19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.celrep.2016.10.037","volume":"17","author":"M Pagac","year":"2016","unstructured":"Pagac, M., Cooper, D. E., Qi, Y., Lukmantara, I. E., Mak, H. Y., Wu, Z., et al. (2016). SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase. Cell reports, 17(6), 1546\u20131559.","journal-title":"Cell reports"},{"key":"5640_CR20","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/srep07633","volume":"5","author":"S Ma","year":"2015","unstructured":"Ma, S., Jing, F., Xu, C., Zhou, L., Song, Y., Yu, C., et al. (2015). Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3. Scientific reports, 5, 7633.","journal-title":"Scientific reports"},{"issue":"6684","key":"5640_CR21","doi-asserted-by":"publisher","first-page":"eadi3332","DOI":"10.1126\/science.adi3332","volume":"383","author":"J Chen","year":"2024","unstructured":"Chen, J., Zhou, Y., Liu, Z., Lu, Y., Jiang, Y., Cao, K., et al. (2024). Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG. Science (New York NY), 383(6684), eadi3332.","journal-title":"Science (New York NY)"},{"issue":"4","key":"5640_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4062\/biomolther.2020.218","volume":"29","author":"JH Song","year":"2021","unstructured":"Song, J. H., Kim, G. T., Park, K. H., Park, W. J., & Park, T. S. (2021). Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease. Biomolecules & therapeutics, 29(4), 373\u2013383.","journal-title":"Biomolecules & therapeutics"},{"issue":"1","key":"5640_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/21623945.2021.2021700","volume":"11","author":"S Chakrabarty","year":"2022","unstructured":"Chakrabarty, S., Bui, Q., Badeanlou, L., Hester, K., Chun, J., Ruf, W., et al. (2022). S1P\/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction. Adipocyte, 11(1), 69\u201383.","journal-title":"Adipocyte"},{"issue":"1","key":"5640_CR24","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1038\/s41598-018-23839-9","volume":"8","author":"M Uil","year":"2018","unstructured":"Uil, M., Scantlebery, A. M. L., Butter, L. M., Larsen, P. W. B., de Boer, O. J., Leemans, J. C., et al. (2018). Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the \u2018resistant\u2019 C57Bl\/6J mouse strain. Scientific reports, 8(1), 5542.","journal-title":"Scientific reports"},{"key":"5640_CR25","doi-asserted-by":"crossref","unstructured":"Chao, P. C., Li, Y., Chang, C. H., Shieh, J. P., Cheng, J. T., & Cheng, K. C. (2018). Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine &. pharmacotherapie,101, 155\u2013161.","DOI":"10.1016\/j.biopha.2018.02.084"},{"issue":"1","key":"5640_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.119.258244","volume":"371","author":"X Zhou","year":"2019","unstructured":"Zhou, X., Muise, E. S., Haimbach, R., Sebhat, I. K., Zhu, Y., Liu, F., et al. (2019). PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy. The Journal of pharmacology and experimental therapeutics, 371(1), 45\u201355.","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"5640_CR27","doi-asserted-by":"crossref","unstructured":"Wang, Z., Liu, Q., Dai, W., Hua, B., Li, H., & Li, W. (2019). Pioglitazone downregulates Twist-1 expression in the kidney and protects renal function of Zucker diabetic fatty rats. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, 118, 109346.","DOI":"10.1016\/j.biopha.2019.109346"},{"key":"5640_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1472-6882-14-110","volume":"14","author":"HJ Lu","year":"2014","unstructured":"Lu, H. J., Tzeng, T. F., Liou, S. S., Da Lin, S., Wu, M. C., & Liu, I. M. (2014). Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC complementary and alternative medicine, 14, 110.","journal-title":"BMC complementary and alternative medicine"},{"issue":"12","key":"5640_CR29","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1074\/jbc.M212307200","volume":"278","author":"JA Chavez","year":"2003","unstructured":"Chavez, J. A., Knotts, T. A., Wang, L. P., Li, G., Dobrowsky, R. T., Florant, G. L., et al. (2003). A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. The Journal of biological chemistry, 278(12), 10297\u201310303.","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"5640_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.kint.2016.01.009","volume":"89","author":"H Yokoi","year":"2016","unstructured":"Yokoi, H., & Yanagita, M. (2016). Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease. Kidney international, 89(4), 740\u2013742.","journal-title":"Kidney international"},{"issue":"12","key":"5640_CR31","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.7150\/ijbs.100394","volume":"20","author":"J Rong","year":"2024","unstructured":"Rong, J., Zhang, Z., Peng, X., Li, P., Zhao, T., & Zhong, Y. (2024). Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome. International journal of biological sciences, 20(12), 4783\u20134798.","journal-title":"International journal of biological sciences"},{"issue":"22","key":"5640_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1042\/CS20180702","volume":"132","author":"W Yang","year":"2018","unstructured":"Yang, W., Luo, Y., Yang, S., Zeng, M., Zhang, S., Liu, J., et al. (2018). Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. Clinical science (London England: 1979), 132(22), 2407\u20132422.","journal-title":"Clinical science (London England: 1979)"},{"issue":"3","key":"5640_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2014). Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. Journal of lipid research, 55(3), 561\u2013572.","journal-title":"Journal of lipid research"},{"issue":"4","key":"5640_CR34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1681\/ASN.2017060627","volume":"29","author":"Y Kim","year":"2018","unstructured":"Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Yoon, H. E., Shin, S. J., et al. (2018). The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes. Journal of the American Society of Nephrology: JASN, 29(4), 1108\u20131127.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"5640_CR35","doi-asserted-by":"publisher","first-page":"155718","DOI":"10.1016\/j.metabol.2023.155718","volume":"150","author":"Z Luo","year":"2024","unstructured":"Luo, Z., Chen, Z., Hu, J., & Ding, G. (2024). Interplay of lipid metabolism and inflammation in podocyte injury. Metabolism: clinical and experimental, 150, 155718.","journal-title":"Metabolism: clinical and experimental"},{"key":"5640_CR36","doi-asserted-by":"publisher","first-page":"155724","DOI":"10.1016\/j.metabol.2023.155724","volume":"150","author":"F Zuo","year":"2024","unstructured":"Zuo, F., Wang, Y., Xu, X., Ding, R., Tang, W., Sun, Y., et al. (2024). CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease. Metabolism: clinical and experimental, 150, 155724.","journal-title":"Metabolism: clinical and experimental"},{"issue":"Pt 5","key":"5640_CR37","doi-asserted-by":"publisher","first-page":"127042","DOI":"10.1016\/j.ijbiomac.2023.127042","volume":"253","author":"Y Qiu","year":"2023","unstructured":"Qiu, Y., Gan, M., Wang, X., Liao, T., Chen, Q., Lei, Y., et al. (2023). The global perspective on peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in ectopic fat deposition: A review. International journal of biological macromolecules, 253(Pt 5), 127042.","journal-title":"International journal of biological macromolecules"},{"key":"5640_CR38","doi-asserted-by":"publisher","first-page":"156776","DOI":"10.1016\/j.phymed.2025.156776","volume":"145","author":"S Zhang","year":"2025","unstructured":"Zhang, S., Wen, Z., Chen, Y., Yang, Y., Song, C., Wang, J., et al. (2025). Keluoxin reduces renal lipid deposition in diabetic nephropathy via AMPK\/NF-\u03baB-mediated mtabolic regulation. Phytomedicine: international journal of phytotherapy and phytopharmacology, 145, 156776.","journal-title":"Phytomedicine: international journal of phytotherapy and phytopharmacology"},{"issue":"3","key":"5640_CR39","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1021\/acs.jafc.4c06122","volume":"73","author":"M Yang","year":"2025","unstructured":"Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., et al. (2025). Sesamol Ameliorates Lipid Deposition by Maintaining the Integrity of the Lipid Droplet-Mitochondria Connection in Diabetic Nephropathy. Journal of agricultural and food chemistry, 73(3), 2124\u20132137.","journal-title":"Journal of agricultural and food chemistry"},{"key":"5640_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/DMSO.S289712","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., Ni, L., Zhang, L., Zha, D., Hu, C., & Zhang, L. (2021). Empagliflozin regulates the adipoR1\/p-AMPK\/p-ACC pathway to alleviate lipid deposition in diabetic nephropathy. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy, 14, 227\u2013240.","journal-title":"Diabetes metabolic syndrome and obesity: targets and therapy"},{"key":"5640_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cca.2021.03.025","volume":"519","author":"Q Li","year":"2021","unstructured":"Li, Q., Li, Y., Lei, C., Tan, Y., & Yi, G. (2021). Sphingosine-1-phosphate receptor 3 signaling. Clinica chimica acta; international journal of clinical chemistry, 519, 32\u201339.","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"5640_CR42","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.phrs.2020.104793","volume":"156","author":"E Jozefczuk","year":"2020","unstructured":"Jozefczuk, E., Guzik, T. J., & Siedlinski, M. (2020). Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology. Pharmacological research, 156, 104793.","journal-title":"Pharmacological research"},{"key":"5640_CR43","doi-asserted-by":"publisher","first-page":"111252","DOI":"10.1016\/j.cellsig.2024.111252","volume":"121","author":"J Piao","year":"2024","unstructured":"Piao, J., Su, Z., He, J., Zhu, T., Fan, F., Wang, X., et al. (2024). SphK1 deficiency ameliorates the development of atherosclerosis by inhibiting the S1P\/S1PR3\/Rhoa\/ROCK pathway. Cellular signalling, 121, 111252.","journal-title":"Cellular signalling"},{"issue":"11","key":"5640_CR44","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1002\/fsn3.4466","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Piao, J., He, J., Su, Z., Luo, Z., & Luo, D. (2024). Hydroxysafflor yellow A, a natural food pigment, ameliorates atherosclerosis in ApoE(-\/-) mice by inhibiting the SphK1\/S1P\/S1PR3 pathway. Food science & nutrition, 12(11), 8939\u20138955.","journal-title":"Food science & nutrition"},{"key":"5640_CR45","doi-asserted-by":"publisher","unstructured":"Keul, P., Peters, S., von Wnuck Lipinski, K., Schr\u00f6der, N. H., Nowak, M. K., & Duse, D. A. (2022). Sphingosine-1-Phosphate (S1P) Lyase inhibition aggravates atherosclerosis and induces plaque rupture in ApoE(-\/-)mice. International Journal of Molecular Sciences, 23(17). https:\/\/doi.org\/10.3390\/ijms23179606","DOI":"10.3390\/ijms23179606"},{"key":"5640_CR46","doi-asserted-by":"crossref","unstructured":"Hu, Y., Yang, C., Shen, G., Yang, S., Cheng, X., Cheng, F. (2019). Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia\/Reperfusion Injury by Regulating M1\/M2 Polarization. Liver Transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 25(7), 1074\u20131090.","DOI":"10.1002\/lt.25470"},{"key":"5640_CR47","doi-asserted-by":"publisher","unstructured":"Wencel, P. L., Czubowicz, K., Gewartowska, M., Frontczak-Baniewicz, M., & Strosznajder, R. P. (2025). Metformin induces changes in sphingosine-1-phosphate-related signaling in diabetic mice brain. International Journal of Molecular Sciences, 26(19). https:\/\/doi.org\/10.3390\/ijms26199832","DOI":"10.3390\/ijms26199832"},{"key":"5640_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1476-511X-10-110","volume":"10","author":"M Mei","year":"2011","unstructured":"Mei, M., Zhao, L., Li, Q., Chen, Y., Huang, A., Varghese, Z., et al. (2011). Inflammatory stress exacerbates ectopic lipid deposition in C57BL\/6J mice. Lipids in health and disease, 10, 110.","journal-title":"Lipids in health and disease"},{"key":"5640_CR49","doi-asserted-by":"publisher","first-page":"983814","DOI":"10.1155\/2012\/983814","volume":"2012","author":"M Snel","year":"2012","unstructured":"Snel, M., Jonker, J. T., Schoones, J., Lamb, H., de Roos, A., Pijl, H., et al. (2012). Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. International journal of endocrinology, 2012, 983814.","journal-title":"International journal of endocrinology"},{"issue":"6","key":"5640_CR50","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1194\/jlr.M001123","volume":"51","author":"K Ravnskjaer","year":"2010","unstructured":"Ravnskjaer, K., Frigerio, F., Boergesen, M., Nielsen, T., Maechler, P., & Mandrup, S. (2010). PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction. Journal of lipid research, 51(6), 1370\u20131379.","journal-title":"Journal of lipid research"},{"issue":"Pt 1","key":"5640_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1113\/jphysiol.2006.111484","volume":"574","author":"M Daval","year":"2006","unstructured":"Daval, M., Foufelle, F., & Ferr\u00e9, P. (2006). Functions of AMP-activated protein kinase in adipose tissue. The Journal of physiology, 574(Pt 1), 55\u201362.","journal-title":"The Journal of physiology"},{"key":"5640_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2020.07.028","volume":"159","author":"S Yao","year":"2020","unstructured":"Yao, S., Yuan, Y., Zhang, H., Meng, X., Jin, L., Yang, J., et al. (2020). Berberine attenuates the abnormal ectopic lipid deposition in skeletal muscle. Free radical biology & medicine, 159, 66\u201375.","journal-title":"Free radical biology & medicine"},{"issue":"4","key":"5640_CR53","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.kint.2018.10.038","volume":"95","author":"X Chen","year":"2019","unstructured":"Chen, X., Han, Y., Gao, P., Yang, M., Xiao, L., Xiong, X., et al. (2019). Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney international, 95(4), 880\u2013895.","journal-title":"Kidney international"},{"issue":"2","key":"5640_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13105-022-00874-9","volume":"78","author":"S Liu","year":"2022","unstructured":"Liu, S., Da, J., Yu, J., Dong, R., Yuan, J., Yu, F., et al. (2022). Renal tubule ectopic lipid deposition in diabetic kidney disease rat model and in vitro mechanism of leptin intervention. Journal of physiology and biochemistry, 78(2), 389\u2013399.","journal-title":"Journal of physiology and biochemistry"},{"key":"5640_CR55","doi-asserted-by":"crossref","unstructured":"Guo, Y., Ran, Z., Zhang, Y., Song, Z., Wang, L., Yao, L., et al. (2020). Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db\/db mice and high glucose-treated HK-2 cells. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, 131, 110684","DOI":"10.1016\/j.biopha.2020.110684"},{"issue":"22","key":"5640_CR56","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1021\/acs.jafc.4c02606","volume":"72","author":"DD Kuang","year":"2024","unstructured":"Kuang, D. D., Li, X. Y., Qian, X. P., Zhang, T., Deng, Y. Y., Li, Q. M., et al. (2024). Tea Polysaccharide Ameliorates High-Fat Diet-Induced Renal Tubular Ectopic Lipid Deposition via Regulating the Dynamic Balance of Lipogenesis and Lipolysis. Journal of agricultural and food chemistry, 72(22), 12582\u201312595.","journal-title":"Journal of agricultural and food chemistry"},{"issue":"5","key":"5640_CR57","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., et al. (2013). PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nature medicine, 19(5), 557\u2013566.","journal-title":"Nature medicine"},{"key":"5640_CR58","doi-asserted-by":"publisher","unstructured":"Idrees, M., Xu, L., El Sheikh, M., Sidrat, T., Song, S. H., & Joo, M. D. (2019). The PPAR\u03b4 agonist GW501516 improves lipolytic\/lipogenic balance through cpt1 and pepck during the development of pre-implantation bovine embryos. International Journal of Molecular Sciences, 20(23). https:\/\/doi.org\/10.3390\/ijms20236066","DOI":"10.3390\/ijms20236066"},{"issue":"6","key":"5640_CR59","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1463-1326.2008.01017.x","volume":"11","author":"D Laurent","year":"2009","unstructured":"Laurent, D., Gounarides, J. S., Gao, J., & Boettcher, B. R. (2009). Effects of cevoglitazar, a dual PPARalpha\/gamma agonist, on ectopic fat deposition in fatty Zucker rats. Diabetes obesity & metabolism, 11(6), 632\u2013636.","journal-title":"Diabetes obesity & metabolism"},{"issue":"18","key":"5640_CR60","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.17420111","volume":"25","author":"DG Hardie","year":"2011","unstructured":"Hardie, D. G. (2011). AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes & development, 25(18), 1895\u20131908.","journal-title":"Genes & development"},{"issue":"6","key":"5640_CR61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia, D., & Shaw, R. J. (2017). AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Molecular cell, 66(6), 789\u2013800.","journal-title":"Molecular cell"},{"issue":"2","key":"5640_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S., & Shaw, R. J. (2018). AMPK: guardian of metabolism and mitochondrial homeostasis. Nature reviews Molecular cell biology, 19(2), 121\u2013135.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"4","key":"5640_CR63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., et al. (2011). AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell metabolism, 13(4), 376\u2013388.","journal-title":"Cell metabolism"},{"issue":"3","key":"5640_CR64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1139\/bcb-2014-0150","volume":"93","author":"PM Marvyn","year":"2015","unstructured":"Marvyn, P. M., Bradley, R. M., Button, E. B., Mardian, E. B., & Duncan, R. E. (2015). Fasting upregulates adipose triglyceride lipase and hormone-sensitive lipase levels and phosphorylation in mouse kidney. Biochemistry and cell biology\u2009=\u2009Biochimie. et biologie cellulaire, 93(3), 262\u2013267.","journal-title":"et biologie cellulaire"},{"key":"5640_CR65","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.molimm.2020.09.020","volume":"128","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Liu, L., Zhang, Q., Shi, W., Feng, W., Wang, J., et al. (2020). Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms. Molecular immunology, 128, 106\u2013115.","journal-title":"Molecular immunology"},{"key":"5640_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.brainres.2017.01.014","volume":"1658","author":"F St-Cyr Gigu\u00e8re","year":"2017","unstructured":"St-Cyr Gigu\u00e8re, F., Attiori Essis, S., Chagniel, L., Germain, M., Cyr, M., & Massicotte, G. (2017). The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices. Brain research, 1658, 51\u201359.","journal-title":"Brain research"},{"issue":"4","key":"5640_CR67","first-page":"460","volume":"1","author":"N Takuwa","year":"2011","unstructured":"Takuwa, N., Du, W., Kaneko, E., Okamoto, Y., Yoshioka, K., & Takuwa, Y. (2011). Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde. American journal of cancer research, 1(4), 460\u2013481.","journal-title":"American journal of cancer research"},{"key":"5640_CR68","doi-asserted-by":"publisher","unstructured":"Maeda, S., Shiimura, Y., Asada, H., Hirata, K., Luo, F., & Nango, E. (2021). Endogenous agonist-bound S1PR3 structure reveals determinants of G protein-subtype bias. Science Advances, 7(24). https:\/\/doi.org\/10.1126\/sciadv.abf5325","DOI":"10.1126\/sciadv.abf5325"},{"issue":"3","key":"5640_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pharmthera.2008.05.008","volume":"119","author":"DS Hutchinson","year":"2008","unstructured":"Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008). Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacology & therapeutics, 119(3), 291\u2013310.","journal-title":"Pharmacology & therapeutics"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05640-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:03:51Z","timestamp":1789200231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5640"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05640-x","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"23 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in strict accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH, USA). The experimental protocol was approved by the Animal Ethics Committee of Yantaishan Hospital (Approval No.: 2024048).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}